Please login to vote

Ideas


Agree 0 Disagree 0

The HPV vaccine risks / efficacy could be determined

By Hicbd
Fri Jun 9 2023 11:43 am

"Vaccinating adults age 26 and older against the human papillomavirus (HPV)—the virus that causes more than 90% of cervical cancers as well as several other cancers—may not be cost-effective, according to a new study led by researchers at the Harvard T.H. School of Public Health."

URL:
https://www.hsph.harvard.edu/news/press-releases/hpv-vaccines-for-adults-not-cost-effective/
https://podcasts.apple.com/us/podcast/truth-about-the-hpv-vaccine-a-megyn-kelly-show/id1532976305?i=1000615769045
https://www.independent.co.uk/life-style/health-and-families/thousands-of-teenage-girls-report-feeling-seriously-ill-after-routine-school-cancer-vaccination-10286876.html
https://www.millerandzois.com/products-liability/gardasil/

URL Credit


Categories:
Personal Health Parenting U.S. Food and Drug Administration (FDA) Immunology / Autoimmune Diseases Cancer Medical / Health Research Investigative Reporting Vaccinations / Vaccines Lawsuits / Personal Injury

----------------------------------------------------------

Please login to comment


Share on Facebook

Share on Twitter

Add to Favorites